Thursday, December 13, 2018 8:10:42 AM
Check-Cap: This Overlooked Medical Device Company Is Extremely Undervalued
Sep. 17, 2018 3:01 PM ET|23 comments| About: Check-Cap Ltd. (CHEK), Includes: EXAS
This article is exclusive for subscribers.
DeepValuePlay
DeepValuePlay
Deep Value, long only, special situations, contrarian
(160 followers)
Summary
The market for polyp diagnosis and colon cancer prevention is huge.
CHEK's share price has the potential to reach $50 within 5 years (14x the current price).
Several positive and significant news went unnoticed by investors - including clinical results that displayed sensitivity of polyp detection increasing from 44% to 76%.
Overhang due to need to raise cash is no longer an issue after a large public offering in May 2018.
Thesis Summary
Check-Cap (NASDAQ:CHEK) is a clinical stage medical devices company engaged in the development of C-Scan. C-Scan is aimed at replacing colonoscopy for colon cancer screening. I believe the company to be extremely undervalued.
Check-Cap was founded in 2004 in Israel and was IPO-ed during 2015. It has since been trading at over $30/share but has recently slumped to just over $3/share with a mere market cap of $18.5M.
Back in October
Recent CHEK News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/13/2024 09:00:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/05/2024 10:07:52 AM
- Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement • PR Newswire (US) • 03/25/2024 11:37:00 PM
- Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement • PR Newswire (Canada) • 03/25/2024 11:15:00 PM
- Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement • PR Newswire (US) • 03/25/2024 11:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/08/2024 02:48:22 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/05/2024 10:00:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/24/2024 10:19:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/11/2024 10:14:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2024 10:15:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/29/2023 01:57:33 PM
- SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD • PR Newswire (US) • 12/22/2023 03:36:00 PM
- SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD • PR Newswire (Canada) • 12/22/2023 03:36:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2023 09:30:10 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/18/2023 11:07:13 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/15/2023 12:30:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/15/2023 12:28:52 PM
- CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL • PR Newswire (Canada) • 12/13/2023 05:37:00 PM
- CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL • PR Newswire (US) • 12/13/2023 05:37:00 PM
- CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES • PR Newswire (Canada) • 12/08/2023 04:18:00 PM
- CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES • PR Newswire (US) • 12/08/2023 04:18:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/07/2023 09:52:56 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 12/07/2023 08:12:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/07/2023 08:10:29 PM
- CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES • PR Newswire (US) • 12/05/2023 08:42:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM